<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(6)</volume><submitter>Ozturk S</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively.&lt;h4>Methods&lt;/h4>We conducted a national, multicenter observational study that included adult maintenance HD patients recovered from confirmed COVID-19. A control HD group without COVID-19 was selected from patients in the same center. We investigated the characteristics and outcomes in the follow-up of HD patients and compare them with the non-COVID-19 group.&lt;h4>Results&lt;/h4>A total of 1223 patients (635 patients in COVID-19 group, 588 patients in non-COVID-19 group) from 47 centers were included in the study. The patients' baseline and HD characteristics were almost similar. The 2</pubmed_abstract><journal>Kidney international reports</journal><pagination>1393-1405</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8949692</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis Patients in Turkey.</pubmed_title><pmcid>PMC8949692</pmcid><pubmed_authors>Can O</pubmed_authors><pubmed_authors>Sakaci T</pubmed_authors><pubmed_authors>Tugcu M</pubmed_authors><pubmed_authors>Dincer MT</pubmed_authors><pubmed_authors>Aydin Z</pubmed_authors><pubmed_authors>Kara E</pubmed_authors><pubmed_authors>Yildiz A</pubmed_authors><pubmed_authors>Aktar M</pubmed_authors><pubmed_authors>Ozer H</pubmed_authors><pubmed_authors>Turgutalp K</pubmed_authors><pubmed_authors>Altunoren O</pubmed_authors><pubmed_authors>Karadag S</pubmed_authors><pubmed_authors>Demir ME</pubmed_authors><pubmed_authors>Kahvecioglu S</pubmed_authors><pubmed_authors>Altiparmak MR</pubmed_authors><pubmed_authors>Dolarslan ME</pubmed_authors><pubmed_authors>Kaya B</pubmed_authors><pubmed_authors>Yuksel E</pubmed_authors><pubmed_authors>Durak BA</pubmed_authors><pubmed_authors>Seyahi N</pubmed_authors><pubmed_authors>Dursun B</pubmed_authors><pubmed_authors>Ozturk S</pubmed_authors><pubmed_authors>Arici M</pubmed_authors><pubmed_authors>Kazan S</pubmed_authors><pubmed_authors>Ozturk R</pubmed_authors><pubmed_authors>Alagoz S</pubmed_authors><pubmed_authors>Pembegul I</pubmed_authors><pubmed_authors>Ayar Y</pubmed_authors><pubmed_authors>Onec K</pubmed_authors><pubmed_authors>Berktas B</pubmed_authors><pubmed_authors>Ates EU</pubmed_authors><pubmed_authors>Gorgulu N</pubmed_authors><pubmed_authors>Sengul E</pubmed_authors><pubmed_authors>Gok M</pubmed_authors><pubmed_authors>Sipahi S</pubmed_authors><pubmed_authors>Kurultak I</pubmed_authors><pubmed_authors>Eren N</pubmed_authors><pubmed_authors>Sahin G</pubmed_authors><pubmed_authors>Ates K</pubmed_authors><pubmed_authors>Ayli MD</pubmed_authors><pubmed_authors>Yilmaz Z</pubmed_authors><pubmed_authors>Gungor O</pubmed_authors><pubmed_authors>Ecder SA</pubmed_authors><pubmed_authors>Huddam B</pubmed_authors><pubmed_authors>Ulu MS</pubmed_authors><pubmed_authors>Bakir EA</pubmed_authors><pubmed_authors>Altun E</pubmed_authors><pubmed_authors>Kocak SY</pubmed_authors><pubmed_authors>Odabas AR</pubmed_authors><pubmed_authors>Ural Z</pubmed_authors><pubmed_authors>Ozler TE</pubmed_authors><pubmed_authors>Demirelli B</pubmed_authors><pubmed_authors>Cebeci E</pubmed_authors><pubmed_authors>Bek SG</pubmed_authors><pubmed_authors>Tonbul HZ</pubmed_authors><pubmed_authors>Sahin GK</pubmed_authors><pubmed_authors>Gencer V</pubmed_authors><pubmed_authors>Colak H</pubmed_authors><pubmed_authors>Eser ZE</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis Patients in Turkey.</name><description>&lt;h4>Introduction&lt;/h4>Hemodialysis (HD) patients have increased risk for short-term adverse outcomes of COVID-19. However, complications and survival at the post-COVID-19 period have not been published extensively.&lt;h4>Methods&lt;/h4>We conducted a national, multicenter observational study that included adult maintenance HD patients recovered from confirmed COVID-19. A control HD group without COVID-19 was selected from patients in the same center. We investigated the characteristics and outcomes in the follow-up of HD patients and compare them with the non-COVID-19 group.&lt;h4>Results&lt;/h4>A total of 1223 patients (635 patients in COVID-19 group, 588 patients in non-COVID-19 group) from 47 centers were included in the study. The patients' baseline and HD characteristics were almost similar. The 2</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-06-01T02:57:43.47Z</modification><creation>2024-11-15T17:03:51.072Z</creation></dates><accession>S-EPMC8949692</accession><cross_references><pubmed>35350104</pubmed><doi>10.1016/j.ekir.2022.03.017</doi></cross_references></HashMap>